“…Indeed from the numerous amygdala tract-tracing studies that have been reported, it is apparent that there are four major regions that contribute axonal projections to the CeA: (1) the medial prefrontal cortex (mPFC) (Ottersen and Ben-Ari, 1979;Neafsey, 1990;Hurley et al, 1991;Fisk and Wyss, 2000); (2) thalamic nuclei, in particular the paraventricular thalamus (PVT) (Su and Bentivoglio, 1990;Turner and Herkenham, 1991;Moga et al, 1995); (3) mesencephalic dopamine centers, primarily the ventral tegmental area (VTA) (Cheung et al, 1998); and (4) brainstem cell groups, including the PB (Fulwiler and Saper, 1984;Bernard et al, 1993;Jia et al, 1994;Chamberlin et al, 1999;Tkacs and Li, 1999), NTS, and ventrolateral medulla (VLM) (Zardetto- Gray, 1990, 1995;Jia et al, 1992;Ciriello, 1993, 1994). However, aside from the aforementioned brainstem lesion study, the contributions of these regions to the recruitment of CeA cells after systemic administration of IL-1 have not been investigated.…”